[1]黄斌,赵纪春,马玉奎,等.糖尿病足下肢动脉闭塞性病变的治疗选择[J]. 现代预防医学,2011,38(12):372-376.
[2]张文夺,姜桂喜,李强,等.经皮腔内血管成形术治疗糖尿病足血管病变90例分析[J].中华普通外科杂志,2011,26(7):283-290.
[3]Romiti M, Albers M, Brochado FC, et al. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg. 2008; 47(5):1-15.
[4]李延铭.糖尿病足的分类分级法与治疗探讨[J].中国误诊学杂志, 2009,9(15):56-61.
[5]史国珍.糖尿病足的内科治疗[J].中国实用内科杂志,2007, 27(7): 39-43.
[6]Ziegler D, Sohr CG, Nourooz J, et al. Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy. Diabetes Care. 2004;27(9): 350-355.
[7]Gnanaraj J, Gnanaraj D, Prasad A, et al. Salvaging a diabetic foot: a new cost-effective method. Trop Doct. 2012;42(2): 88-89.
[8]Valabhji J. Foot problems in pstients with diabetes and chronic kidney disese. J Renal Care. 2012;38(10): 99-108.
[9]Kawamoto A, Asahara T, Losordo DW, et al. Transplantation of endothelial progenitor cells for therapeutic neovascularization. Cardiovasc Radiat Med. 2002;3(4):221 - 251.
[10]邢帅,陈剑秋,梁瑜祯,等.干细胞移植治疗下肢缺血性疾病的研究进展[J]. 国际检验医学杂志,2012,33(1):55-58.
[11]王寅冬,王爱林.超声消融联合自体干细胞移植治疗糖尿病足临床分析[J].黑龙江医学,2009,33(2):135-137.
[12]Broun MA.,Zhang L, Levering VW, et al. Human Umbilical Cord Blood–Derived Endothelial Cells Reendothelialize Vein Grafts and Prevent Thrombosis. Arterioscler Thromb Vasc Biol. 2010; 30(11): 2150-2155.
[13]Konstantinos S, Harald L, Gnerlich S, et al. Junctional Adhesion Molecule A Expressed on Human CD34+ Cells Promotes Adhesion on Vascular Wall and Differentiation Into Endothelial Progenitor Cells. Arterioscler Thromb Vasc Biol. 2010;30(6): 1127-1136.
[14]Choi K, Kennedy M, Kazarov A, et al. A common precursor for hematopoietic and endothelial cells. Development. 1998; 125(4): 725-732.
[15]Iba O, Matssubara H, Nozawa Y, et al. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation. 2002;106(15): 2019-2025.
[16]Assmus B, Tonn T, Seeger FH, et al. Red Blood Cell Contamination of the Final Cell Product Impairs the Efficacy of Autologous Bone Marrow Mononuclear Cell Therapy. J Am Coll Cardiol. 2010;55(13): 1385-1394 .
[17]Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348(7): 593-600.
[18]Bogoslovsky T, Spatz M, Chaudhry A, et al. Circulating CD133+CD34+ progenitor cells inversely correlate with soluble ICAM-1 in early ischemic stroke patients. J Transl Med. 2011; 26(9):145.
[19]Fadini GP, Avogaro A. Potential manipulation of endothelial progenitor cells in diabetes and its complications. Diabetes Obes Metab. 2010;12(7): 570-583.
[20]Steinmetz M, Nickenig G, Werner N, et al. Endothelial-regenerating cells: an expanding universe. Hypertension. 2010;55(3): 593-599.
[21]Fadini GP, Boscaro E, Kreutzenberg S, et al. Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes. Diabetes Care. 2010;33(5): 1097-1102.
[22]Toshner M, Voswinckel R, Southwood M, et al. Evidence of Dysfunction of Endothelial Progenitors in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2009;180(8): 780-787.
[23]Jude EB, Oyibo SO, Chalmers N, et al. Peripheral arterial diseasein diabetic and nondiabetic patients: a comparison of severity outcome. Diabetes Care. 2001;24(8):1433-1437.
[24]杨晓凤,徐波,王慧,等.家兔自体外周干细胞移植治疗下肢缺血的实验研究[J]. 中国实用内科杂志, 2005, 25(12):1103-1104.
[25]郭连瑞,谷涌泉,张建,等.不同途径移植骨髓单个核细胞治疗大鼠后肢缺血[J].中国临床康复, 2005, 9(10):57-60.
[26]Colombo E, Marconi C, Taddeo A, et al. Fast reduction of peripheral blood endothelial progenitor cells in healthy humans exposed to acute systemic hypoxia. J Physiol. 2012; 590(3): 519-532.
[27]徐寒松,雷闽湘,孔德明,等.体外高浓度葡萄糖培养及黄芪干预人外周血内皮祖细胞的数量和增殖与分化[J]. 中国组织工程研究与临床康复, 2011,15(32):6027-6031.
[28]Liao YF, Chen LL, Zeng TS, et al. Number of circulating endothelial progenitor cells as a marker of vascular endothelial function for type2 diabetes. Vasc Med. 2010;15(4): 279-285.
[29]郑伟红,万亚峰. 从PBMCs及CD133免疫磁珠分选获得内皮祖细胞的体外研究[J]. 中国病理生理杂志,2010, 26(2):368-373.
[30]Fadini GP,Sartore S,Albiero M,et al.Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol. 2006;26(9): 2140-2146.
[31]Maruotti N, Cantatore FP, Crivellato E, et al. Angiogenesis in rheumatoid arthritis. Histol Histopathol. 2006;21(5):557-566.
[32]Carmona G, Chavakis E, Koehl U,et al.Activation of Epac stimulates integrindependent homing of progenitor cells. Blood. 2008;111(5): 2640-2646.
[33]Gilcrease M. Integrin signaling in epithelial cells. Cancer Lett. 2007;247(25): 1-25.
[34]Silvestre JS, Thery C, Hamard G, et al. Lactadherin promotes VEGF-dependent neovascularization. Nat Med. 2005;11(5): 499-506.
[35]Eliceiri BP, Cheresh DA. Role of alpha v integrins during angiogenesis. Cancer J. 2000;6(Suppl 3) : S245-249.
[36]刘文韬,陈国玉,夏建国,等.胃癌微卫星不稳定性与血管内皮生长因子表达关系的研究[J].医学研究生学报, 2007, 18(2): 37-40.
[37]Yoon YS, Johnson IA, Park JS, et al. Therapeutic myocardial angiogenesis with vascular endothelial growth factors . Mol Cell Biochem. 2004;264 (1-2) : 63-74.
[38]Weis S, Shintani S, Weber A, et al. Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction. J Clin Invest. 2004;113(6): 885-894.
[39]Tsou R, Isik FF. Integrin activation is required for VEGF and FGF receptor protein presence on human microvascular endothelial cells. Mol Cell Biochem. 2001; 224(1-2):81-99.
[40]Byzova TV, Goldman CK, Pampori N, et al. Amechanism for modulation of cellular responses to VEGF: activation of the integrins. Mol Cel. 2000;6(4):851-860.
[41]Borges E, Jan Y, Ruoslahti E. Platelet-derived Growth Factor Receptor β and Vascular Endothelial Growth Factor Receptor 2 Bind to the β3Integrin through Its Extracellular Domain. J Biol Chem. 2000;275(51):39867-39873.
[42]Goyal A, Pal N, Concannon M, et al. Endorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a dual receptor antagonism. J Biol Chem. 2011;286(29):25947-25962.
[43]Rapraeger AC, Find all citations by this author (default). Or filter your current search Ell BJ, Find all citations by this author (default).Or filter your current search Roy M,VE-cadherin Stimulates Syndecan-1-Coupled IGF1R and Cross-Talk between alphaVbeta3 Integrin and VEGFR2 During the Onset of Endothelial Cell Dissemination in Angiogenesis. FEBS J. 2013;19(10):1111.
[44]Kockx MM, Knaapen MW. The role of apoptosis in vascular disease. J Pathol. 2000;190(3): 267-280.
[45]Jain S, Ward MM, O'Loughlin J, et al. Incremental increase in VEGFR1+ hematopoietic progenitor cells and VEGFR2+ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients. Breast Cancer Res Treat. 2012;132(1): 235-242.
[46]Asahara T, Takahashi T, Masuda H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. Embo J. 1999; 18(14): 3964-3972.
[47]Fadini GP, Sartore S, Agostini C, et al. Significance of endothelial progenitor cells in subjects with diabetes. Diabetes Care. 2007;30(51):1305-1313.
[48]付秀立,赵湜,王红祥,等.糖尿病周围血管病患者内皮祖细胞一氧化氮、内皮型一氧化氮合酶含量的变化[J].中国现代医学杂志, 2010,20(2):251-258.
[49]Chavakis E, Aieher A, Heesehen C, et al. Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells. J Exp Med. 2005;201(1): 63-72.
[50]Rey S, Semenza GL. Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovasc Res. 2010;86(2): 236-242.
[51]李桂林,杨宝钟.内皮祖细胞在血管新生及血管组织工程化过程中的生物学意义[J].基础医学与临床,2010,30(3):333-336.
[52]Emmanouil C, Guillaume C, Urbich C, et al. Phosph-atidylinositol-3-Kinase-γ is integral to homing functions of progenitor cells. Circ Res. 2008;102(8): 942-949.
[53]McCall KD, Zutter M. Collagen receptor integrins: rising to the challenge. Curr Drug Targets. 2008;9(2): 139-149.
[54]董鹏,王玉环,张春虹. 血管内皮祖细胞在糖尿病周围血管并发症中的作用及治疗策略[J]. 医学综述, 2009,15(23):3630-3633.
[55]Bogatcheva NV, Garcia JG, Verin D, et al. Role of tyrosine kinase signaling in endothelial cell barrier regulation. Vascul Pharmacol. 2003;39(4/5): 201-212 .
[56]Gahmberg CG, Fagerholm SC, Nurmi SM, et al. Regulation of integrin activity and signaling. Biochim Biophys Act. 2009; 1790 (6): 431-444.
[57]Dvorak HF. Discovery of vascular permeability factor(VPF). Exp Cell Res. 2006;312(5): 522-526.
[58]Gavrilovskaya IN, Gorbunove EE, Mackow NA, et al. Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability. J Virol. 2008;82(12): 5797-5806.
[59]Woodard AS, GarciaCardena G, Leong M, et al. The synergistic activity of alphavbeta 3 integrin and PDGF receptor increases cell migrati on. J Cell Sci. 1998;111(Pt 4): 469-478.
[60]王伟,李彧,王平忠,等.汉坦病毒感染对β3 整合素及血管内皮生长因子受体2 的作用[J].中国病毒病杂志, 2011,1(4):254-259. |